Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Pfizer
Pfizer
Myrexis Undervalued As BioPharma Transforms
Seeking Alpha
Mon, 05/14/12 - 10:20 am
Myrexis
JNJ
Abbott Laboratories
Pfizer
Why Johnson & Johnson Looks Better Than Its Competitors
Seeking Alpha
Mon, 05/14/12 - 10:19 am
JNJ
Human Genome Sciences
Pfizer
Sanofi
Edwards Lifesciences
GSK
AstraZeneca
5 Fantastic Healthcare Dividends For The Income Investor
Seeking Alpha
Sat, 05/12/12 - 11:54 am
Cardinal Health
HCP
JNJ
Merck
Pfizer
Pfizer: Is 8 Really Enough?
Seeking Alpha
Sat, 05/12/12 - 11:26 am
Pfizer
tofacitinib
rheumatoid arthritis
Watson Has Double-Digit Upside, But Peers Are 'Strong Buys'
Seeking Alpha
Fri, 05/11/12 - 12:36 pm
Watson Pharmaceuticals
JNJ
Novartis
Pfizer
Pfizer Set To Surge On 3 New Drug Candidates
Seeking Alpha
Fri, 05/11/12 - 12:22 pm
Pfizer
Abbott Laboratories
Amgen
AstraZeneca
Watson Pharmaceuticals
JNJ
Bristol-Myers Squibb
Analysis And Valuation: J&J, Pfizer, Merck
Seeking Alpha
Fri, 05/11/12 - 11:26 am
JNJ
Merck
Pfizer
These 2 Pharma Giants Explain Critical New Developments
Wall St. Cheat Sheet
Fri, 05/11/12 - 11:23 am
Pfizer
JNJ
generics
Lipitor
Thermacool
More drug companies to pay billions for fraud, join the "dishonor roll" after Abbott settlement
Forbes
Fri, 05/11/12 - 11:21 am
whistleblower lawsuits
Abbott Laboratories
Pfizer
GSK
Eli Lilly
JNJ
FDA panel favors novel arthritis drug from Pfizer
Yahoo/AP
Thu, 05/10/12 - 10:57 am
FDA
advisory panels
Pfizer
rheumatoid arthritis
tofacitinib
Pfizer's Must-Win FDA Vote
Motley Fool
Tue, 05/8/12 - 07:18 pm
FDA
Pfizer
rheumatoid arthritis
tofacitinib
Amgen
JNJ
Merck
Abbott Laboratories
Bright Future Ahead Of Abbott Despite Mounting Competition
Seeking Alpha
Tue, 05/8/12 - 07:17 pm
Abbott Laboratories
Merck
Nestle
Pfizer
Roche
Sanofi
Pfizer Should Rise On New Gaucher Drug, Due Out In 2013
Seeking Alpha
Tue, 05/8/12 - 10:53 am
Pfizer
Gaucher disease
GSK
AstraZeneca
Eli Lilly
Shire
Protalix BioTherapeutics
Elelyso
Roche's Pain May Be Merck's Gain
Seeking Alpha
Mon, 05/7/12 - 11:16 am
Roche
Merck
dalcetrapib
Abbott Laboratories
Bristol-Myers Squibb
Gilead
Eli Lilly
Pfizer
Sanofi
Illumina
Eli Lilly's Valuation May Prove To Be A Good Investment Opportunity
Seeking Alpha
Mon, 05/7/12 - 11:13 am
Eli Lilly
Amylin
GSK
Novo Nordisk
Pfizer
Sanofi
Pfizer Arthritis Pill Raises Safety Concerns, FDA Staff Says
Bloomberg
Mon, 05/7/12 - 11:12 am
Pfizer
tofacitinib
rheumatoid arthritis
FDA
Quark Pharma extends pact with Pfizer to develop compounds containing Silence’s AtuRNAi
Pharmabiz
Sat, 05/5/12 - 04:38 pm
Pfizer
Quark Pharmaceuticals
Silence Therapeutics
PF-655
Open-Angle Glaucoma
diabetic macular oedema
AtuRNAi
Pfizer’s Lipitor Losing U.K. Patent Protection, the Times Says
Bloomberg
Sat, 05/5/12 - 01:03 pm
Pfizer
Lipitor
patents
These 5 Big Healthcare Stocks Have Major Upside In 2013
Seeking Alpha
Sat, 05/5/12 - 12:58 pm
Pfizer
Eli Lilly
Merck
Abbott Laboratories
PDL Biopharma
Pfizer Plan to Buy Stock, Raise Dividends Overshadows Growth Strategy
Minyanville
Sat, 05/5/12 - 12:42 pm
Pfizer
Pages
« first
‹ previous
…
221
222
223
224
225
226
227
228
229
…
next ›
last »